Found 0 matching trials
Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
PHASE2Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Location
Sierra Eye Associates
An Exploratory Study by Fast CAR T Cells
EARLY_PHASE1The main goal of this trial is to evaluate the safety and tolerability of C...
Location
Shanghai Mengchao Cancer Hospital
Class II Invariant Chain HCV Vaccine Study
PHASE1The study is aimed at assessing the safety and immunogenicity of HCV prime-...
Location
Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
PHASE1This is a multicenter, open-label, ascending-dose trial of the safety and t...
Reactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine
PHASE1The study is a single centre, phase I, open, randomized, by intranasal and ...
Location
National Center for Tuberculosis Problems, Kazakhstan
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
PHASE1This Phase I/IIa clinical study is testing an experimental treatment called...
Location
Hospital Clínic de Barcelona
Oral Evaluation by the Nurses From the Office of Access to Healthcare ("PASS") for Vulnerable People - PASSDENT Study
NAOral health is defined as the state of being free from dental or periodonta...
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
PHASE1This study is a single-center, open Phase I study, to observe the effective...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
PHASE1The study is divided into 2 parts. In the first part, the safety of the gen...
Location
University of California at San Diego Medical Center
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Chinese PLA General Hospital